Heart Failure Acute
32
9
11
5
Key Insights
Highlights
Success Rate
63% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
9.4%
3 terminated out of 32 trials
62.5%
-24.0% vs benchmark
22%
7 trials in Phase 3/4
100%
5 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (32)
Contrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure
Congestion and LActate at diScHarge in Acute Heart Failure
Continuous Remote ECG Monitoring to Predict 30-day Outcome After Hospital Discharge in Patients With Heart Failure : A Pilot Study Using a New Wearable Sensor
Evaluation and Support Care Process Within the Care Pathway of Heart Failure Patients
Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advanced Practice Providers
Simulation-Based Cardiac Point-of-Care Ultrasound Program to Improve Clinical Outcomes in Acute Heart Failure Patients
Vexus Assessment and Natriuresis-guided Diuretic Therapy in Acute Heart Failure
Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients
Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
Remote Monitoring After Heart Failure
Evaluation of the Effectiveness of the CardioStory Device in Distinguishing Heart Failure From Other Causes in Patients Presenting With Dyspnea
Prediction of Heart-Failure with Machine Learning
Nitroglycerin vs. Furosemide Using Lung Ultrasound Pilot Trial
SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF
B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial
Prognostic Model Heart Failure
Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure
Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure
Acetazolamide or Metolazone in Acute Heart Failure
Lesser Poland Cracovian Heart Failure Registry